16 results
8-K
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 22
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
4:14pm
as filed with the Securities and Exchange Commission on May 12, 2022.
John H. Markels, Ph.D., age 56, has over 35 years of leadership experience … , Managing Director, Mexico from November 2013 to January 2017. Prior to his commercial roles, he had a long career in senior leadership positions
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 22
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
4:14pm
. Markels has over 35 years of leadership experience in the pharmaceutical industry at Merck & Co., Inc., with a deep background in manufacturing … leadership positions in major regions worldwide in manufacturing technology, operations, supply chain and strategy. Dr. Markels has worked in every region
DEFR14A
15aw xcydii71df1
12 May 22
Revised proxy
5:00pm
8-K
EX-99.1
djjxdh2qsvx6 m0nqq
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
EX-99.1
lg65bvcb
7 Nov 19
Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
4:53pm
DEF 14A
wh4h96b rqeavw
1 Oct 19
Definitive proxy
6:07am
8-K12B
iws1mes8pt0 n6tksyg9
14 Jun 19
Notification of registration of securities
5:10pm
424B3
701mdjpbg0e9rt2bjjd
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
z1o0clxq50 c7
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
gr3ddo2m
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next